Sycnosis India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 20-12-2024
- Paid Up Capital ₹ 0.70 M
as on 20-12-2024
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Revenue -74.24%
(FY 2021)
- Profit -75980.72%
(FY 2021)
- Ebitda -153.86%
(FY 2021)
- Net Worth -968.55%
(FY 2021)
- Total Assets 8.75%
(FY 2021)
About Sycnosis India
The Corporate was formerly known as Josh Healthcare Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.70 M, as per Ministry of Corporate Affairs (MCA) records.
Seema Mishra, Om Mishra, Jai Mishra, and One other member serve as directors at the Company.
- CIN/LLPIN
U74120UP2013PLC055805
- Company No.
055805
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Mar 2013
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Varanasi, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sycnosis India Limited offer?
Sycnosis India Limited offers a wide range of products and services, including Ayurvedic Pain Relief Oil, Ayurvedic Joint Pain Relief Oil, Ayurvedic Immunity Booster, Ayush Kwath, Ayurvedic Digestive Medicine, Ayurvedic Digestive Syrups, Ayurvedic Cosmetics, Ayurvedic Hair Oil, Confectionery Ingredients, Liquid Malt Extract.
Who are the key members and board of directors at Sycnosis India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Seema Mishra  | Director | 22-Mar-2013 | Current |
| Om Mishra | Director | 22-Mar-2013 | Current |
| Jai Mishra | Director | 30-Dec-2016 | Current |
| Rajat Mishra | Director | 30-Dec-2016 | Current |
Financial Performance of Sycnosis India.
Sycnosis India Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 74.24% decrease. The company also saw a substantial fall in profitability, with a 75980.72% decrease in profit. The company's net worth observed a substantial decline by a decrease of 968.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sycnosis India?
In 2021, Sycnosis India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kartikay Pharmaceuticals Private LimitedActive 7 years 1 monthSeema Mishra and Rajat Mishra are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sycnosis India?
Unlock and access historical data on people associated with Sycnosis India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sycnosis India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sycnosis India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
